Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-08-16

FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for GILENYA (fingolimod hydrochloride) submitted by Novartis Pharmaceuticals Corporation; the approval updates the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GILENYA (FINGOLIMOD HCL)

Snippet

SUPPL AP for GILENYA (FINGOLIMOD HCL)